Disclosure Panels Details Page
Multiple Myeloma/Systemic Light Chain Amyloidosis/Waldenström Macroglobulinemia Panel - Disclosures as of 05/24/2019
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Muhamed Baljevic MD | None | Amgen Inc. Cardinal Health Specialty Solutions E1A11: Randomized Phase III Trial of Bortezomib, LENalidomide and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, Dexamethasone (CRd) Followed by Limited or Indefinite DURation Lenalidomide MaintenANCE in Patients with Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE) Exelixis Inc. GLG Janssen Pharmaceutica Products, LP Karyopharm Therapeutics Olson Research Group Inc. Phase II Multicenter Trial of Single Autologous Hematopoietic Cell Transplant Followed by Lenalidomide Maintenance for Multiple Myeloma with or without Vaccination with Dendritic Cell/Myeloma Fusions (BMT CTN 1401) Takeda Pharmaceuticals North America, Inc. |
None | None | ✔ |
| Marian Birkeland PhD | None | None | None | None | - |
| Natalie Callander MD | None | None | None | None | ✔ |
| Erica Campagnaro MD | None | None | None | None | ✔ |
| Jorge Castillo MD | AbbVie, Inc. BeiGene Janssen Pharmaceutica Products, LP Pharmacyclics |
BeiGene Janssen Pharmaceutica Products, LP Pharmacyclics |
None | None | ✔ |
| Jason Chandler MD | None | None | AbbVie, Inc. | None | - |
| Robert Cornell MD, MPH | None | Karyopharm Therapeutics Takeda Pharmaceuticals North America, Inc. |
None | None | ✔ |
| Caitlin Costello MD | None | Celgene Corporation Millennium Pharmaceuticals, Inc. |
None | None | ✔ |
| Sarah DeVincenzo PharmD, BCPS | None | Decision Resources Group Consulting | None | None | ✔ |
| Yvonne Efebera MD, MPH | None | None | Janssen Pharmaceutica Products, LP Karyopharm Therapeutics Takeda Pharmaceuticals North America, Inc. |
None | ✔ |
| Matthew Faiman MD, MBA, FACP | None | None | None | None | - |
| Alfred Garfall MD | Amgen Inc. Janssen Pharmaceutica Products, LP Novartis Pharmaceuticals Corporation Tmunity |
Surface Oncology Tmunity |
None | None | ✔ |
| Kelly Godby MD | None | None | None | None | - |
| Kristina Gregory MSN, RN | None | None | None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Kyle Herrmann BSN, RN, OCN | None | None | None | None | ✔ |
| Jens Hillengass MD, PhD | Amgen Inc. Celgene Corporation Janssen Pharmaceutica Products, LP |
Amgen Inc. Janssen Pharmaceutica Products, LP |
None | None | ✔ |
| Leona Holmberg MD, PhD | Bristol Myers Squibb Juno Therapeutics, Inc. Merck & Co., Inc. Millennium Pharmaceuticals, Inc. sanofi-aventis U.S. Seattle Genetics, Inc. |
Jazz Phamaceuticals | None | Up-To-Date | - |
| Myo Htut MD | Celgene Corporation Janssen Pharmaceutica Products, LP Juno Therapeutics, Inc. Merck & Co., Inc. Roche Laboratories, Inc. |
None | None | None | - |
| Carol Ann Huff MD | Glenmark Pharmaceuticals Johnson & Johnson Karyopharm Therapeutics |
Celgene Corporation Johnson & Johnson Karyopharm Therapeutics miDiagnostics sanofi-aventis U.S. |
None | None | ✔ |
| Alyse Johnson-Chilla MS | None | None | None | None | ✔ |
| Yubin Kang MD | Celgene Corporation Incyte Corporation |
Takeda Pharmaceuticals North America, Inc. | None | None | ✔ |
| Ann Karosas RPh, BCOP | None | None | None | None | - |
| Jennifer Keller MS | None | None | None | None | ✔ |
| Rashmi Kumar PhD | None | None | None | None | ✔ |
| Shaji Kumar MD | AbbVie, Inc. Amgen Inc. Bristol Myers Squibb Janssen Pharmaceutica Products, LP Kite Pharma MedImmune Inc. Merck & Co., Inc. Roche Laboratories, Inc. sanofi-aventis U.S. Takeda Pharmaceuticals North America, Inc. |
AbbVie, Inc. Adaptive Technologies Amgen Inc. Celgene Corporation Janssen Pharmaceutica Products, LP Oncopeptides Roche Laboratories, Inc. Takeda Pharmaceuticals North America, Inc. |
None | None | ✔ |
| Ola Landgren MD, PhD | Amgen Inc. Celgene Corporation Janssen Pharmaceutica Products, LP Merck & Co., Inc. Takeda Pharmaceuticals North America, Inc. |
Amgen Inc. Bristol Myers Squibb Celgene Corporation Janssen Pharmaceutica Products, LP Karyopharm Therapeutics Merck & Co., Inc. Pfizer Inc. Takeda Pharmaceuticals North America, Inc. |
None | None | ✔ |
| Michaela Liedtke MD | Agios, Inc. Amgen Inc. BlueBirdBio Celator Pharmaceuticals Celgene Corporation Genentech, Inc. Gilead Sciences, Inc. Janssen Pharmaceutica Products, LP Pfizer Inc. Prothena Takeda Pharmaceuticals North America, Inc. |
Adaptive Gilead Sciences, Inc. Janssen Pharmaceutica Products, LP Jazz Pharmaceuticals Inc. |
None | None | ✔ |
| Ehsan Malek MD | NA | NA | NA | NA | - |
| Thomas Martin MD | Amgen Inc. sanofi-aventis U.S. |
None | None | None | - |
| Jim Omel MD | None | None | None | None | - |
| Sharon Park PharmD, BCOP | None | None | None | None | - |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Noopur Raje MD | None | AstraZeneca Pharmaceuticals LP Celgene Corporation Janssen Pharmaceutica Products, LP Novartis Pharmaceuticals Corporation Roche Laboratories, Inc. Takeda Pharmaceuticals North America, Inc. |
Amgen Celegene |
None | - |
| Leslie Ray PharmD | None | None | None | None | - |
| Douglas Sborov MD, MSc | Bristol Myers Squibb Celgene Corporation GSK Janssen Pharmaceutica Products, LP sanofi-aventis U.S. |
Janssen Pharmaceutica Products, LP | None | None | ✔ |
| Seema Singhal MD | Abbott Laboratories Array Janssen Pharmaceutica Products, LP Onyx Pharmaceuticals, Inc. |
None | Celgene Corporation Millennium Pharmaceuticals, Inc. |
None | - |
| Jack Skinner PhD | None | None | None | None | - |
| Keith Stockerl-Goldstein MD | Cellerant Therapeutics, Inc. | None | Celgene Corporation | AbbVie, Inc. | - |
| Carlyn Rose Tan MD | None | None | None | None | - |
| Donna Weber MD | Merck & Co., Inc. Novartis Pharmaceuticals Corporation |
None | None | None | - |